The University of Washington received a $155,942 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "TRANSCUTANEOUS ELECTRODE-INDUCED VALSALVA-LIKE MANEUVER FOR THE PREVENTION OF BLAST INDUCED PATHOPHYSIOLOGY AND BEHAVIORAL DEFICITS IN THE FERRET". The award, which began on September 15, 2024 and has a projected completion date of May 14, 2027, will support the University's investigation into...
The Defense Health Agency awarded a $250,000 Project Grant to Rutgers, The State University of New Jersey to conduct research titled "BOOSTING MYELINATION USING VISUAL FLICKER IN THE ACUTE CUPRIZONE INTOXICATION MODEL". The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate medical solutions for the battlefield through basic, applied, and advanced biomedical research. The project is scheduled to be completed...
The Department of the Army Medical Command awarded Rutgers, The State University of New Jersey a $751,587 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research targeting adenosine kinase for the prevention of post-traumatic epilepsy from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
The Defense Health Agency awarded Rutgers, The State University a $471,000 project grant under the Military Medical Research and Development program (CFDA 12.420) to develop new therapeutic strategies for chemo brain in ovarian cancer survivors. The grant period runs from July 1, 2023 through June 30, 2027 in New Brunswick, New Jersey. Through its Research Financial Services division, Rutgers will leverage its expertise in bioengineering and disease research to investigate medical solutions...
The federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a $1,126,946 research initiative aimed at cardiovascular risk profiling of deployment-related respiratory diseases. The grant was awarded on November 1, 2024 to the Veterans Bio-Medical Research Institute, Inc., a non-profit research organization located in East Orange, New Jersey. This translational research project investigates innovative...
The University of Auckland in New Zealand was awarded a $534,258 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research applying enhanced electroceutical treatments and identifying electrical biomarkers for spinal cord injury from September 1, 2023 through August 31, 2026. As part of its mission to transform military and public health through innovative medical research solutions, the Defense Health...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
This $250,000.00 Project Grant awarded by the Air Force Research Laboratory under the Air Force Defense Research Sciences Program (CFDA 12.800) will fund research by the New Jersey Institute of Technology (NJIT) to advance the understanding of transformers, state space models, and diffusion models for dynamical systems. The award has a performance period from September 1, 2024 to September 14, 2027. As a well-established academic research institution, NJIT has a robust track record of securing...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...